Follow The Filings

ONCO Onconetix

Onconetix earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -1.28 —
Rev — — —

Insider trades

Open-market buys and sales by ONCO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ONCO insider trades
  • $153K bought by 1 insider
  • $144K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Hrt Financial LP 10% owner
    Sale
    $34K 49,710 shares at $0.6900 60% of stake
    Traded Apr 21 Filed Apr 22
  2. Hrt Financial LP 10% owner
    Buy
    $25K 34,636 shares at $0.7300 +24% to stake
    Traded Apr 17 Filed Apr 21
  3. Hrt Financial LP 10% owner
    Sale
    $110K 148,329 shares at $0.7400 64% of stake
    Traded Apr 16–20 Filed Apr 21
  4. Hrt Financial LP 10% owner
    Buy
    $128K 166,904 shares at $0.7600 +554% to stake
    Traded Apr 14–15 Filed Apr 16

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A DEFINITIVE PROXY STATEMENT
8-K 1.01,7.01,9.01
DEFA14A CURRENT REPORT
424B3 PROSPECTUS
S-1/A AMENDMENT NO. 1 TO FORM S-1
10-Q QUARTERLY REPORT
S-1 REGISTRATION STATEMENT
8-K 1.01,3.02,9.01
SCHEDULE 13G —
424B3 PROSPECTUS
S-1 REGISTRATION STATEMENT
8-K 5.03,8.01,9.01
8-K 8.01,9.01
10-Q QUARTERLY REPORT
424B3 PROSPECTUS
S-1/A AMENDMENT NO. 1 TO FORM S-1
8-K 5.07,9.01
S-1 REGISTRATION STATEMENT
8-K 5.02,9.01
DEF 14A DEFINITIVE PROXY STATEMENT
8-K 5.03,8.01,9.01
8-K/A 5.02,9.01
8-K 5.02,9.01
10-K ANNUAL REPORT
8-K 1.01,8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.